"/> Invitrogen™ Peptide synthétique BCL2A1 humain | B-LABO France

Invitrogen™ Peptide synthétique BCL2A1 humain

Réf. : BL-RE-176412Réf. fabricant : 15216599 50 μg
137,00 € HT

Synthetic Peptide

Gene ID (Entrez)
597
Espèces
Human
Méthode de purification
purified
Numéro d’adhésion
Q16548
Nom usuel
Human BCL2A1
Marque
Invitrogen

Bfl-1 Synthetic Peptide, PEP-0384, from Invitrogen.

Bcl-2 related Protein A1 is a member of the BCL-2 protein family. The proteins of this family form hetero- or homodimers and act as anti- and pro-apoptotic regulators that are involved in a wide variety of cellular activities such as embryonic development, homeostasis and tumorigenesis. The protein encoded by this gene is able to reduce the release of pro-apoptotic cytochrome c from mitochondria and block caspase activation. This gene is a direct transcription target of NF-kappa B in response to inflammatory mediators, and has been shown to be up-regulated by different extracellular signals, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), CD40, phorbol ester and inflammatory cytokine TNF and IL-1, which suggests a cytoprotective function that is essential for lymphocyte activation as well as cell survival.

Caractéristiques techniques

MarqueInvitrogen
Réf. B-LABOBL-RE-176412
Réf. fabricant15216599
Gene ID (Entrez)597
EspècesHuman
Méthode de purificationpurified
Numéro d’adhésionQ16548
Nom usuelHuman BCL2A1
Concentration200 μg/mL
Contenu et stockage-20°C
FormatLiquid
FormulePBS with 0.1% BSA and 0.02% sodium azide; pH 7.2
À utiliser avec (application)Blocking Assay, Control
Symbole de gène(s)BCL2A1
LyophiliséNo
Conservateur0.02% sodium azide
Type de produitPeptide
Quantité50 μg
État réglementaireRUO - research use only
Tampon de stockagePBS
Une question, une configuration particulière ?
Contactez-nous pour un devis.